Skip to main content

Table 3 Remission rate of different diseases

From: Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome

Disease types

CR (cases)

PR (cases)

NR (cases)

Total

Effective rate (%)

MN

9

17

10

36

72.2

MsPGN

6

4

1

11

90.9

MCN

10

4

1

15

93.3

FSGS

0

0

5

5

0

SLE

5

16

5

26

80.7

HSPN

5

2

0

7

100

Total

35

43

22

100

78% (78/100)

  1. MN: membranous nephropathy; MsPGN: mesangial proliferative glomerulonephritis; MCN: minimal change nephropathy; FSGS: focal segmental glomerulosclerosis; SLE: systemic lupus erythematosus; HSPN: Henoch - Schonlein purpura nephritis;